Christa E. Macdonald

85 Park Road
Grafton, AUK 1023, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Neuroprotective activity of new Δ3-N-acylethanolamines in a focal ischemia stroke model.

Neuroprotective activity of new Δ3-N-acylethanolamines in a focal ischemia stroke model.

Journal: Lipids

Published: August 05, 2021

Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA.

Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA.

Journal: ACS chemical neuroscience

Published: October 15, 2020

Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA.

Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA.

Journal: ACS chemical neuroscience

Published: September 13, 2019

Divalent cannabinoid-1 receptor ligands: A linker attachment point survey of SR141716A for development of high-affinity CB1R molecular probes.

Divalent cannabinoid-1 receptor ligands: A linker attachment point survey of SR141716A for development of high-affinity CB1R molecular probes.

Journal: Bioorganic & medicinal chemistry letters

Published: June 07, 2019

Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor.

Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor.

Journal: ACS medicinal chemistry letters

Published: November 29, 2018

The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs.

The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs.

Journal: Drug testing and analysis

Published: September 29, 2018

Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.

Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.

Journal: Drug testing and analysis

Published: February 02, 2018

Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.

Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.

Journal: European journal of medicinal chemistry

Published: September 23, 2017

Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two.

Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two.

Journal: Cannabis and cannabinoid research

Published: September 02, 2017

Real-Time Measurement of Cannabinoid Receptor-Mediated cAMP Signaling.

Real-Time Measurement of Cannabinoid Receptor-Mediated cAMP Signaling.

Journal: Methods in enzymology

Published: July 29, 2017

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.

Journal: Nature communications

Published: March 17, 2016

Application of xCELLigence RTCA Biosensor Technology for Revealing the Profile and Window of Drug Responsiveness in Real Time.

Application of xCELLigence RTCA Biosensor Technology for Revealing the Profile and Window of Drug Responsiveness in Real Time.

Journal: Biosensors

Published: February 20, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026